David Zigdon

David Zigdon serves as CEO of MIGAL Galilee Research Institute and President of MigVax, while also holding multiple board member positions at organizations including BELKIN Laser Ltd., Moebius Medical Ltd., and Vascular Graft Solutions. Since January 2019, David has been a member of the Board of Advisors for Zigdon Enterprises. Previous board memberships include ProJini, Everads Therapy Ltd., Perflow Medical, and Radiaction Ltd., showcasing extensive leadership in the medical and technology sectors. David holds a BA in Economic and Accounting and an LLM in Law from Bar-Ilan University.